Therefore, it is very important to select and study targets capable of blocking pro-inflammatory (IL-13, IL-17, and IL-33) or inducing anti-inflammatory interleukin (IL-10) in the complex process of liver fibrosis. This evidence concerns the gene IL17A and Hepatic fibrosis.